Senna and Zinc sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Senna and Zinc sulfate. Common interactions include arthralgia among females and pancytopenia among males.

The phase IV clinical study analyzes what interactions people who take Senna and Zinc sulfate have. It is created by eHealthMe based on reports of 81 people who take Senna and Zinc sulfate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 27, 2022

81 people who take Senna and Zinc sulfate together, and have interactions are studied.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 31,906 Senna users for its effectiveness, alternative drugs and more.

What is Zinc sulfate?

Zinc sulfate has active ingredients of zinc sulfate. It is often used in zinc deficiency. eHealthMe is studying from 2,542 Zinc sulfate users for its effectiveness, alternative drugs and more.

Number of Senna and Zinc sulfate reports submitted per year:

Common Senna and Zinc Sulfate drug interactions by gender *:

female:

Arthralgia
Back pain
Cardiac failure congestive
Chronic kidney disease
Dyspnoea exertional
Febrile neutropenia
Gait disturbance
Hyponatraemia
Infection
Lung squamous cell carcinoma stage unspecified

male:

Pancytopenia
Hepatic encephalopathy
Muscle spasms
Muscular weakness
Non-cardiac chest pain
Paranoia
Psychotic behaviour
Thrombocytopenia
Impaired healing
Acute myocardial infarction

Common Senna and Zinc Sulfate drug interactions by age *:

0-1:

n/a

2-9:

Hypotension
Renal impairment
Circulatory collapse
Rash macular

10-19:

Drug rash with eosinophilia and systemic symptoms
Abdominal pain
Drug hypersensitivity
Faecal volume increased
Headache
Hypotension
Lactic acidosis
Leukopenia
Lymphadenopathy
Mouth ulceration

20-29:

Acute chest syndrome
Acute prerenal failure
Cardiac arrest
Circulatory collapse
Coagulopathy
Compartment syndrome
Diarrhoea
Dizziness
Dyspnoea
Enterobacter test positive

30-39:

n/a

40-49:

Abnormal behaviour
Aggression
Anaemia
Hallucinations, mixed
Hypotension
Pancytopenia
Paranoia
Psychotic behaviour
Thrombocytopenia
Abdominal pain upper

50-59:

Osteopenia
Osteoporosis
Tooth fracture
Tooth loss
Wrist fracture
Ammonia increased
Asthenia
Biliary tract disorder
Diarrhoea
Fatigue

60+:

Pneumonia
Fall
Arthralgia
Back pain
Decubitus ulcer
Dyspnoea exertional
Gait disturbance
Gastrointestinal haemorrhage
Hypotension
Lung squamous cell carcinoma stage unspecified

Common conditions people have *:

Pain: 21 people, 25.93%
Multiple Myeloma (cancer of the plasma cells): 12 people, 14.81%
Hepatitis C: 11 people, 13.58%
Nausea (feeling of having an urge to vomit): 8 people, 9.88%
Fever: 8 people, 9.88%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 6.17%
Hypotension (abnormally low blood pressure): 5 people, 6.17%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and Zinc sulfate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.